| 发明名称 |
Crystallization method and bioavailability |
| 摘要 |
CRYSTALLIZATION METHOD AND BIOAVAILABILITY The disclosure relates to preparation, in-vitro and in vivo characterization of novel forms of (1 -hydroxy-2-imidazol- 1-yl-1 -phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. |
| 申请公布号 |
AU2016219654(A1) |
申请公布日期 |
2016.09.15 |
| 申请号 |
AU20160219654 |
申请日期 |
2016.08.25 |
| 申请人 |
THAR PHARMACEUTICALS, INC. |
发明人 |
HANNA, MAZEN;SHAN, NING;CHENEY, MIRANDA;WEYNA, DAVID;HOUCK, RAYMOND K. |
| 分类号 |
A61K31/675;A61P3/14;A61P19/08;A61P19/10;A61P35/04;C07F9/6506 |
主分类号 |
A61K31/675 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
